8.680USD-0.46%Mkt Cap: 106.64M $P/E: 43.402d ago
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astig…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap106.64M $
Enterprise Value106.29M $
Revenue (TTM)60.26M $
Gross Profit27.12M $
Net Income (TTM)-34.28M $
Revenue/Share4.962 USD
Last Price8.680 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees150
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)43.40
P/E (Forward)-11.89
PEG—
EV/EBITDA-6.51
EV/Revenue1.76
P/S1.72
P/B6.95
EPS (TTM)0.19
EPS (Forward)-0.71
52W Range
4.95047% of range12.96
52W High12.96 USD
52W Low4.950 USD
Profitability
Gross Margin46.41%
Oper. Margin12.94%
EBITDA Margin-27.09%
Profit Margin-58.66%
ROE131.75%
ROA-47.99%
Growth
Revenue Growth18.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.83M $
CapEx (TTM)83.00K $
FCF Margin-40.47%
FCF Yield-22.87%
Net Debt-11.18M $
Net Debt/EBITDA0.68
Balance Sheet
Debt/Equity-0.11
Current Ratio2.39
Quick Ratio1.03
Book Value/Sh1.214 USD
Cash/Share1.104 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.50 USD
Upside (mean)+32.5%
Target Range10.00 USD – 13.00 USD
$10.00+32.5% to mean$13.00
# Analysts2
Ownership
Shares Out.12.29M
Float8.84M
Insiders21.52%
Institutions45.98%
Short Interest
Short Ratio10.7d
Short % Float5.09%
Short % Out.3.67%
Shares Short451.09K
Short (prev mo.)505.44K
Technical
SMA 506.093 (+42.5%)
SMA 2008.466 (+2.5%)
Beta0.88
S&P 52W Chg18.16%
Avg Vol (30d)129.76K
Avg Vol (10d)342.31K
Technical Indicators
RSI (14)81.9
MACD0.6166
MACD Signal0.2685
MACD Hist.+0.3482
BB Upper8.478 USD
BB Middle6.172 USD
BB Lower3.867 USD
BB Width74.70%
ATR (14)0.4521 USD
Vol Ratio (20d)0.92x